Neuropathy Device Maker Files

NeuroMetrix, Inc., a Massachusetts-based medical device company, has filed a 510(k) form with the US Food and Drug Administration for the SENSUSTM, a pain therapy device for people who suffer diabetic neuropathy. A 510(k) is a “premarket notification” of a company’s intent to market a medical product. The FDA then tests the product and provides feedback to the manufacturer

Keep Your Fingers Crossed: FDA Approves Artificial Pancreas Outpatient Trial

The FDA has approved the start of outpatient trials of a smart phone-based monitoring device that functions as an artificial pancreas.

Summer Eating Tips for People With Diabetes

As we approach the summer season, our thoughts turn to barbecues, picnics, amusement parks, and road trips to the beach.

Metformin Could Protect Women Against Endometrial Cancer

British researchers say that metformin, the drug most often used to treat prediabetes and type 2 diabetes, could provide potential protection against endometrial cancer in women.

Routine Tests Can Identify Risk of Gestational Diabetes Years Before Pregnancy

Up to seven years before she becomes pregnant, a woman’s risk of developing diabetes during pregnancy can be identified based on routinely assessed measures of blood sugar and body weight, according to a Kaiser Permanente study published in the online issue of the American Journal of Obstetrics and Gynecology.